ArticleAnnals of translational medicine2026

Does lung adenocarcinoma subtyping offer clinical benefits?-a retrospective population-based cohort study from Sweden.

Frantisek Zitricky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.